Ray Dalio’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$863K Buy
41,562
+35,100
+543% +$829K ﹤0.01% 812
2025
Q4
$210K Sell
6,462
-119,319
-95% -$5.11M ﹤0.01% 1036
2025
Q3
$7.13M Sell
125,781
-472,248
-79% -$24.2M 0.03% 406
2025
Q2
$29.8M Sell
598,029
-148,896
-20% -$6.73M 0.12% 133
2025
Q1
$22.1M Buy
746,925
+735,345
+6,350% +$27.3M 0.1% 166
2024
Q4
$280K Sell
11,580
-289,492
-96% -$7.17M ﹤0.01% 637
2024
Q3
$5.55M Buy
301,072
+117,251
+64% +$2.1M 0.03% 360
2024
Q2
$3.71M Buy
183,821
+81,128
+79% +$1.35M 0.02% 415
2024
Q1
$1.59M Buy
+102,693
New +$1.16M 0.01% 525

Other funds holding HIMS

Ray Dalio's HIMS Position: Q1 2026 in Review

Ray Dalio increased its Hims & Hers Health (HIMS) stake by 543% in Q1 2026, buying an estimated $829K and bringing the position to 41,562 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Ray Dalio first reported a position in HIMS in Q1 2024 and has held it in 9 quarters since. The position peaked at $29.8M in Q2 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Ray Dalio held 41,562 shares of Hims & Hers Health worth $863K as of Q1 2026.
  • Ray Dalio bought 35,100 Hims & Hers Health shares in Q1 2026, an estimated $829K.
  • Hims & Hers Health made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #812 holding.
  • Ray Dalio first reported a position in Hims & Hers Health in Q1 2024 and has held it in 9 quarters since.
  • Ray Dalio's Hims & Hers Health position peaked at $29.8M in Q2 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.